Yahoo
OTC Markets OTCPK - Delayed Quote USD

Adaptimmune Therapeutics plc (ADAPY)

0.0200 +0.0010 (+5.26%)
At close: November 6 at 4:00:00 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
65,085
178,032
60,281
27,148
6,149
Cost of Revenue
3,450
70
0
0
--
Gross Profit
61,635
177,962
60,281
27,148
--
Operating Expense
207,271
230,371
198,319
191,113
168,395
Operating Income
-145,636
-52,409
-138,038
-163,965
-162,246
Net Non Operating Interest Income Expense
-647
3,248
5,964
1,542
1,095
Other Income Expense
-19,762
-18,077
19,539
-536
3,852
Pretax Income
-166,045
-67,238
-112,535
-162,959
-157,299
Tax Provision
3,711
3,576
1,336
2,497
791
Net Income Common Stockholders
-169,756
-70,814
-113,871
-165,456
-158,090
Diluted NI Available to Com Stockholders
-169,756
-70,814
-113,871
-165,456
-158,090
Basic EPS
-0.66
-0.30
-0.54
-1.02
-1.02
Diluted EPS
-0.66
-0.30
-0.54
-1.02
-1.02
Basic Average Shares
258,224.4350
252,301.8090
201,073.4960
161,207.0670
155,805.5030
Diluted Average Shares
258,224.4350
252,301.8090
201,073.4960
161,207.0670
155,805.5030
Total Operating Income as Reported
-164,220
-68,760
-139,741
-163,965
-162,246
Total Expenses
210,721
230,441
198,319
191,113
168,395
Net Income from Continuing & Discontinued Operation
-169,756
-70,814
-113,871
-165,456
-158,090
Normalized Income
-155,818
-58,550.7500
-130,351.2600
-165,456
-158,090
Interest Income
5,018
6,596
5,964
1,542
1,095
Interest Expense
5,665
3,348
0
0
--
Net Interest Income
-647
3,248
5,964
1,542
1,095
EBIT
-160,380
-63,890
-112,535
-162,959
-162,246
EBITDA
-149,752
-52,665
-102,695
-156,884
-155,679
Reconciled Cost of Revenue
3,450
70
0
0
--
Reconciled Depreciation
10,628
11,225
9,840
6,075
6,567
Net Income from Continuing Operation Net Minority Interest
-169,756
-70,814
-113,871
-165,456
-158,090
Total Unusual Items Excluding Goodwill
-18,584
-16,351
20,346
0
0
Total Unusual Items
-18,584
-16,351
20,346
0
0
Normalized EBITDA
-131,168
-36,314
-123,041
-156,884
-155,679
Tax Rate for Calcs
0.0003
0.0003
0.0002
0.0002
0.0002
Tax Effect of Unusual Items
-4,646
-4,087.7500
3,865.7400
0
0
12/31/2021 - 5/6/2015

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: